Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 13, Number 4—April 2007
Synopsis

Human Benefits of Animal Interventions for Zoonosis Control

Jakob Zinsstag*Comments to Author , Esther Schelling*†, Felix Roth*, Bassirou Bonfoh*‡, Don de Savigny*, and Marcel Tanner*
Author affiliations: *Swiss Tropical Institute, Basel, Switzerland; †International Livestock Research Centre, Nairobi, Kenya; ‡Institut du Sahel, Bamako, Mali;

Main Article

Table 1

Distribution of benefits and suggested allocation of intervention costs for livestock brucellosis mass vaccination campaign in Mongolia*†

Cost Benefit Net present value‡ Benefit: cost ratio§
Total agriculture sector 5,174.9 16,611.6 11,436.7 3.2
Human health
  Public health sector
     Central government 1,009.4 3,240.3 2,230.9 3.2
     Health Insurance Fund 0.0 0.0 0.0
  Patient
     Out-of-pocket contribution to health costs 1,669.3 5,358.7 3,689.4 3.2
     Change in household income 1,103.7 3,542.8 2,439.1 3.2
Total overall human health 3,782.4 12,141.8 8,359.4 3.2
Total private sector 7,947.9 25,513.1 17,565.2 3.2
Total society 8,957.3 28,753.4 19,796.1 3.2

*Scenario for proportion of protected animals at 52% and discount rate at 5%. Costs are in Mongolian tugriks; 1 US$ ≈1,080 MNT in October 2000.
†Table reproduced from (4).
‡Benefits minus costs.
§Benefits divided by costs (minimum 2.27, maximum 4.37).

Main Article

References
  1. Smith  NH, Gordon  SV, Rua-Domenech  R, Clifton-Hadley  RS, Hewinson  RG. Bottlenecks and broomsticks: the molecular evolution of Mycobacterium bovis. Nat Rev Microbiol. 2006;4:67081. DOIPubMed
  2. Bonfoh  B, Wasem  A, Traoré  AN, Fan é A, Spillmann H, Simbé CF, et al. Microbiological quality of cows’ milk taken at different intervals from the udder to the selling point in Bamako (Mali). Food Contr. 2003;14:495500. DOI
  3. Steinmann  P, Bonfoh  B, Peter  O, Schelling  E, Traore  M, Zinsstag  J. Seroprevalence of Q-fever in febrile individuals in Mali. Trop Med Int Health. 2005;10:6127. DOIPubMed
  4. Roth  F, Zinsstag  J, Orkhon  D, Chimed-Ochir  G, Hutton  G, Cosivi  O, Human health benefits from livestock vaccination for brucellosis: case study. Bull World Health Organ. 2003;81:86776.PubMed
  5. Klempner  MS, Shapiro  DS. Crossing the species barrier—one small step to man, one giant leap to mankind. N Engl J Med. 2004;350:11712. DOIPubMed
  6. Zinsstag  J, Schelling  E, Wyss  K, Bechir  M. Potential of cooperation between human and animal health to strengthen health systems. Lancet. 2005;366:21425. DOIPubMed
  7. Osofsky  SA, Cleaveland  S, Karesh  WB, Kock  MD, Nyhus  PJ, Starr  L, Conservation and development interventions at the wildlife/livestock interface: implications for wildlife, livestock and human health. Gland (Switzerland) and Cambridge (UK): The World Conservation Union; 2005.
  8. Cook  RA, Karesh  WB, Osofsky  SA. Building interdisciplinary bridges to health in a globalized world. Presented at One World One Health Symposium, 2004 Sep 29; New York. [cited 2007 Feb 14]. Available from http://www.oneworldonehealth.org/sept2004/owoh_sept04.html.
  9. Lundervold  M, Milner-Gulland  EJ, O'Callaghan  CJ, Hamblin  C, Corteyn  A, Macmillan  AP. A serological survey of ruminant livestock in Kazakhstan during post-Soviet transitions in farming and disease control. Acta Vet Scand. 2004;45:21124. DOIPubMed
  10. Zinsstag  J, Roth  F, Orkhon  D, Chimed-Ochir  G, Nansalmaa  M, Kolar  J, A model of animal-human brucellosis transmission in Mongolia. Prev Vet Med. 2005;69:7795. DOIPubMed
  11. Madkour  AA. Madkour’s brucellosis. Berlin: Springer Verlag; 2001.
  12. Warrell  DA, Warrell  MJ. Human rabies: a continuing challenge in the tropical world. Schweiz Med Wochenschr. 1995;125:87985.PubMed
  13. Knobel  DL, Cleaveland  S, Coleman  PG, Fevre  EM, Meltzer  MI, Miranda  ME, Re-evaluating the burden of rabies in Africa and Asia. Bull World Health Organ. 2005;83:3608.PubMed
  14. Wandeler  AI, Matter  HC, Kappeler  A, Budde  A. The ecology of dogs and canine rabies: a selective review. Rev Sci Tech. 1993;12:5171.PubMed
  15. Bögel  K, Meslin  FX. Economics of human and canine rabies elimination: guidelines for programme orientation. Bull World Health Organ. 1990;68:28191.PubMed
  16. Kayali  U, Mindekem  R, Yemadji  N, Vounatsou  P, Kaninga  Y, Ndoutamia  AG, Coverage of pilot parenteral vaccination campaign against canine rabies in N’Djaména, Chad. Bull World Health Organ. 2003;81:73944.PubMed
  17. Kayali  U, Mindekem  R, Hutton  G, Ndoutamia  AG, Zinsstag  J. Cost-description of a pilot parenteral vaccination campaign against rabies in dogs in N’Djaména, Chad. Trop Med Int Health. 2006;11:105865. DOIPubMed
  18. Cleaveland  S, Fevre  EM, Kaare  M, Coleman  PG. Estimating human rabies mortality in the United Republic of Tanzania from dog bite injuries. Bull World Health Organ. 2002;80:30410.PubMed
  19. Zeitlin  GA, Maslow  MJ. Avian influenza. Curr Infect Dis Rep. 2005;7:1939. DOIPubMed
  20. Gensheimer  KF, Meltzer  MI, Postema  AS, Strikas  RA. Influenza pandemic preparedness. Emerg Infect Dis. 2003;9:16458.PubMed
  21. Digoutte  JP. Present status of an arbovirus infection: yellow fever, its natural history of hemorrhagic fever, Rift Valley fever [in French]. Bull Soc Pathol Exot. 1999;92:3438.PubMed
  22. Hotez  PJ, Molyneux  DH, Fenwick  A, Ottesen  E, Ehrlich  SS, Sachs  JD. Incorporating a rapid-impact package for neglected tropical diseases with programs for HIV/AIDS, tuberculosis, and malaria. PLoS Med. 2006;3:e102. DOIPubMed
  23. Utzinger  J, de Savigny  D. Control of neglected tropical diseases: integrated chemotherapy and beyond. PLoS Med. 2006;3:e112. DOIPubMed
  24. Mfinanga  SG, Morkve  O, Kazwala  RR, Cleaveland  S, Sharp  JM, Shirima  G, The role of livestock keeping in tuberculosis trends in Arusha, Tanzania. Int J Tuberc Lung Dis. 2003;7:695704.PubMed
  25. International Pledging Conference on Avian and Human Pandemic Influenza; 2006 Jan 17–18; Beijing.
  26. Murray  CJL, Lopez  AD, eds. Global comparative assessments in the health sector: disease burden, expenditures and interventions packages. Geneva: World Health Organization; 1994.
  27. Benenson  AS. Control of communicable diseases in man. Washington (DC): American Public Health Association; 1985.
  28. Gsell  O, Mohr  W, eds. Infectious diseases [in German]. Berlin: Springer Verlag; 1968.

Main Article

Page created: June 28, 2010
Page updated: June 28, 2010
Page reviewed: June 28, 2010
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external